$MSGS

Madison Square Garden Sports (MSGS) plans to spin off the New York Knicks and Rangers into separate publicly traded companies, potentially unlocking value. The Knicks' valuation is estimated at $13B-$14B, based on the Lakers' recent $12.5B sale. MSGS stock has risen from $180 to $403 since March 2025. A 2027 tax-law change may incentivize teams to go private, reducing investment opportunities.

MSG Sports plans to separate the Knicks and Rangers into separate public companies, according to LightShed Partners. The move aims to close the valuation gap between public and private markets. Both teams face negative free cash flow and may need capital. A minority stake sale and eventual private ownership are likely outcomes, benefiting current investors.

Aviva (AV.) reported H1 operating profit up 24% to £1.3bn, driven by general insurance profit up 40% to £905mn from Direct Line integration, and raised its interim dividend 7% to 14p. It restarted buybacks and generated £100mn run-rate synergies. GB Group (GBG) shares fell after higher-than-expected US attrition and guidance cut. Frasers (FRAS) bought Harvey Nichols stores from administration. Cohort (CHRT) said Elac won a €141mn Saab sonar contract. Madison Square Garden Sports (MSGS) saw reven

Madison Square Garden Sports Corp. said the Knicks’ championship run boosted Q4 and full-year results. Playoff-related revenue rose $66.9M year over year, helped by higher per-game playoff revenue and merchandise sales. FY 2026 revenue increased to $1.15B (+$114.6M). Q4 revenue rose to $278.7M (+37%).

Madison Square Garden Sports Corp. (MSGS) filed an SEC Form 8-K — Results of Operations and Financial Condition. MADISON SQUARE GARDEN SPORTS CORP. REPORTS FISCAL 2026 FOURTH QUARTER AND FULL-YEAR RESULTS Fiscal 2026 Highlighted by the New York Knicks Winning the NBA Championship Proposed Spin-off of New York Rangers Business Expected to be Completed by the End of October 2026 NEW YORK, N.Y

Analysts issued multiple Wall Street calls, including UBS initiating Crescent Energy (CRGY) with Buy and $13 target, and UBS initiating SM Energy (SM) with Buy and $36 target. Raymond James reiterated Nvidia (NVDA) as strong buy. UBS reiterated SpaceX as buy, citing a July 16 Starship test flight. Deutsche Bank reiterated Tesla (TSLA) ahead of earnings. Citi lowered Microsoft (MSFT) target to $570 from $620.

On May 28, analysts adjusted price targets across multiple stocks. Agilent’s target was cut by Wells Fargo ($165→$160) but raised by Barclays ($140→$145) and TD Cowen ($147→$155). Affirm’s target rose at Truist ($75→$80). Bath & Body Works saw mixed changes, while Salesforce targets were mostly lowered by several firms.

The MSG Family of Companies, including Madison Square Garden Sports Corp., Madison Square Garden Entertainment Corp., and Sphere Entertainment Corp., have announced a multi-year partnership with Lenovo and its subsidiary Motorola Mobility. This collaboration designates Lenovo and Motorola as Official Partners across MSG's venues and franchises, focusing on community engagement initiatives like supporting small businesses and high-profile in-venue activations, such as Motorola Razr presenting Celebrity Row. The partnership aims to enhance fan experiences, expand brand presence, and integrate Lenovo's technology throughout MSG's operations.

JPMorgan Chase & Co. has increased its stake in The Madison Square Garden Company (MSGS) by 11.8% in the third quarter, purchasing an additional 12,412 shares to hold a total of 117,905 shares valued at approximately $26.8 million. This acquisition makes JPMorgan Chase & Co. the owner of 0.49% of Madison Square Garden. The company recently reported an earnings miss in its quarterly results, but revenue saw a 12.7% increase, leading to a consensus "Hold" rating from analysts with an average target price of $286.

JPMorgan Chase & Co. has raised its target price for Madison Square Garden (NYSE:MSGS) stock from $240.00 to $305.00, maintaining an "overweight" rating and suggesting a potential upside of 9.24%. Despite this positive outlook, the stock currently holds a consensus "Hold" rating from multiple analysts with an average price target of $272.17. The company recently reported quarterly earnings of $0.34 per share, missing consensus estimates, but revenue exceeded expectations at $403.42 million.